Patients with rheumatoid arthritis (RA) report substantial improvement of fatigue after beginning anti–tumor necrosis factor α (TNF-α) therapy. In particular, employed women with a low level of disability were the most likely to experience an improvement in fatigue. Pain, however, was not a significant predictor of improvement in fatigue.

Click Here to read more